Repligen (RGEN) Tops Q3 EPS by 10c ; Offers Guidance
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $121.73 +0.50%
Revenue Growth %: +10.7%
Financial Fact:
Research and development: 1.89M
Today's EPS Names:
CRMT, REPL, HURC, More
Revenue Growth %: +10.7%
Financial Fact:
Research and development: 1.89M
Today's EPS Names:
CRMT, REPL, HURC, More
Join SI Premium – FREE
Repligen (NASDAQ: RGEN) reported Q3 EPS of $0.43, $0.10 better than the analyst estimate of $0.33. Revenue for the quarter came in at $155 million versus the consensus estimate of $153.22 million.
GUIDANCE:
Repligen sees FY2024 EPS of $1.50-$1.58, versus the consensus of $1.49. Repligen sees FY2024 revenue of $630-639 million, versus the consensus of $629.7 million.
For earnings history and earnings-related data on Repligen (RGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
- Petco Health and Wellness (WOOF) Misses Q1 EPS by 6c
- Oil-Dri raises dividend for 23rd consecutive year, authorizes buybacks
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
